cas 133261-06-0|| where to buy ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate

Produktname:ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate

IUPAC Name:ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM106500-5g	in stock	ǜȺƀ
CM106500-10g	in stock	ǜȁǊ
CM106500-25g	in stock	ưƎǊ
CM106500-100g	in stock	ȁȬǊ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:133261-06-0; Molekulare Formel:C9H12N2O2; Schmelzpunkt:-; SMILES-Code:O=C(C1=NNC(C2CC2)=C1)OCC; Dichte:

: Katalognummer:CM106500; Molekulargewicht:180.21; Siedepunkt:352.0±30.0°C at 760 mmHg; Mdl-Nr.:MFCD08277218; Lagerung:Store at 2-8°C.

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.